Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Risk factors of HCV seroconversion in hemodialysis patients in tabriz, iran.

Somi MH, Etemadi J, Ghojazadeh M, Farhang S, Faramarzi M, Foroutan S, Soleimanpour M.

Hepat Mon. 2014 Jun 1;14(6):e17417. doi: 10.5812/hepatmon.17417. eCollection 2014 Jun.

2.

Hepatitis C antibodies in patients on peritoneal dialysis: prevalence and risk factors.

Lee GS, Roy DK, Fan FY, Thanaletchumi K, Woo KT.

Perit Dial Int. 1996;16 Suppl 1:S424-8.

3.

Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.

Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW.

Kidney Int. 2004 Jun;65(6):2335-42.

PMID:
15149347
4.
6.

Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the middle east.

Saxena AK, Panhotra BR, Sundaram DS, Naguib M, Venkateshappa CK, Uzzaman W, Mulhim KA.

Am J Infect Control. 2003 Feb;31(1):26-33.

PMID:
12548254
7.

[Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].

Resić H, Sahović V, Mesić E, Leto E.

Acta Med Croatica. 2003;57(1):39-42. Croatian.

PMID:
12876861
8.

Hepatitis C virus seroconversion and genotype prevalence in patients and staff on chronic hemodialysis.

Zamir D, Storch S, Zonder HB, Zamir C, Weiner P.

J Clin Gastroenterol. 1999 Jan;28(1):23-8.

PMID:
9916660
9.

Hepatitis C virus infection in haemodialysis: the 'no-isolation' policy should not be generalized.

Agarwal SK, Dash SC, Gupta S, Pandey RM.

Nephron Clin Pract. 2009;111(2):c133-40. doi: 10.1159/000191208. Epub 2009 Jan 16.

PMID:
19147995
11.

[Infection by hepatitis C virus in patients on hemodialysis: prevalence and risk factors].

Leão JR, Pace FH, Chebli JM.

Arq Gastroenterol. 2010 Jan-Mar;47(1):28-34. Portuguese.

12.

Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation?

Harmankaya O, Cetin B, Obek A, Seber E.

Ren Fail. 2002 Sep;24(5):639-44.

PMID:
12380910
13.

Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients.

Gohar SA, Khalil RY, Elaish NM, Khedr EM, Ahmed MS.

J Egypt Public Health Assoc. 1995;70(5-6):465-84.

PMID:
17214170
14.

Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study.

Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, Alavian SM.

J Med Virol. 2006 May;78(5):569-73.

PMID:
16555284
15.

Prevalence and risk factors of hepatitis B and C viruses among hemodialysis patients in Isfahan, Iran.

Kalantari H, Ebadi S, Yaran M, Maracy MR, Shahshahan Z.

Adv Biomed Res. 2014 Jan 27;3:73. doi: 10.4103/2277-9175.125869. eCollection 2014.

16.

Hepatitis B and C and renal failure.

Zacks SL, Fried MW.

Infect Dis Clin North Am. 2001 Sep;15(3):877-99. Review.

PMID:
11570146
17.

Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus.

Yuan J, Yang Y, Han F, Zhang P, Du XY, Jiang H, Chen JH.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):302-6.

18.

Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients.

Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S.

Nephrology (Carlton). 2003 Oct;8(5):256-60.

PMID:
15012714
19.

Patient to patient transmission of hepatitis C virus in hemodialysis units.

Taskapan H, Oymak O, Dogukan A, Utas C.

Clin Nephrol. 2001 Jun;55(6):477-81.

PMID:
11434360
20.

Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines.

Tu AW, Buxton JA, Whitlock M, Djurdjev O, Chong M, Krajden M, Beaulieu M, Levin A.

Can J Infect Dis Med Microbiol. 2009 Summer;20(2):e19-23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk